Publication | Closed Access
Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment
49
Citations
34
References
2011
Year
On the basis of preclinical activity and safety, Genz-644282 was selected for development and is currently undergoing phase 1 clinical trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1